FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | MENS | CDXS | ||
| Company | FS Development Corp II Cl A | Jyong Biotech Ltd | Codexis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 2.69 | 2.21 | ||
| High | 10.16 | 2.74 | 2.24 | ||
| Low | 9.69 | 2.69 | 2.20 | ||
| Latest | 9.80 | 2.74 | 2.24 | ||
| Change | -0.20 | +0.06 | +0.03 | ||
| % Change | -2.00% | +2.05% | +1.36% | ||
| Volume | 289,100 | 5,456 | 81,188 | ||
| 20-Day Average Volume | 227,795 | 184,865 | 3,723,880 | ||
| Previous Close | 10.00 | 2.68 | 2.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 2.12 | 1.72 | ||
| 20-Day Raw Stochastic | 2.99% | 90.31% | 97.59% | ||
| 20-Day Relative Strength | 38.90 | 47.37 | 70.25 | ||
| Weighted Alpha | -13.88 | -39.34 | +8.37 | ||
| Today's Opinion | 8% Buy | 48% Sell | 24% Buy | ||
| Previous Opinion | 8% Buy | 56% Sell | 24% Buy | ||
| Last Month's Opinion | 72% Buy | 56% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | +17.98% since 04/01/26 | +27.59% since 04/01/26 | ||
| Low | 9.64 on 12/21/21 | 2.14 on 04/02/26 | 1.67 on 04/02/26 | ||
| High | 10.86 on 12/21/21 | 2.80 on 04/08/26 | 2.24 on 04/09/26 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | +14.47% since 03/09/26 | +77.60% since 03/09/26 | ||
| Low | 9.64 on 12/21/21 | 1.66 on 03/20/26 | 1.18 on 03/11/26 | ||
| High | 15.00 on 12/01/21 | 2.80 on 04/08/26 | 2.24 on 04/09/26 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | -29.40% since 01/09/26 | +35.37% since 01/09/26 | ||
| Low | 9.64 on 12/21/21 | 1.43 on 02/11/26 | 0.96 on 03/04/26 | ||
| High | 15.05 on 11/19/21 | 4.10 on 01/20/26 | 2.24 on 04/09/26 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | -95.02% since 10/09/25 | -17.16% since 10/09/25 | ||
| Low | 9.64 on 12/21/21 | 1.43 on 02/11/26 | 0.96 on 03/04/26 | ||
| High | 15.05 on 11/19/21 | 63.00 on 10/23/25 | 2.93 on 10/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 203,755 | 200,821 | ||
| Shares Outstanding, K | 20,727 | 76,028 | 90,869 | ||
| Annual Sales | 0 | 0 | 70,390,000 | ||
| Annual Net Income | 0 | -3,019,000 | -43,970,000 | ||
| Last Quarter Sales | 0 | N/A | 38,920,000 | ||
| Last Quarter Net Income | -1,220,000 | N/A | 9,600,000 | ||
| 60-Month Beta | N/A | N/A | 2.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | N/A | 0.11 on 03/11/26 | ||
| Latest Earnings Date | 01/01/70 | N/A | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||